DRUG FACTS:
- Manufacturer
- Life Choice Ltd. | Apotheca Company
- Effective date
- 2026-06-22
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- monthly-update
- Hydrated at
- 2026-07-17 21:34:15
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS:
CAUSTICUM 3X, NATRUM MURIATICUM 3X, CALCAREA IODATA 6X, FUCUS VESICULOSUS 6X, KALI IODATUM 6X, FERRUM IODATUM 8X, THYROIDINUM (BOVINE) 8X
RECOMMENDED USE:
Homeopathic remedy used to help relieve symptoms such as weakness, fatigue, cold hands and feet, dry skin, chilliness, headaches, and constipation.
Duration of Use: Consult a health care practitioner if symptoms persist or worsen.
CAUTION / RISK INFORMATION:
Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding.
Keep out of reach of children. Do not use if security seal is broken.
KEEP OUT OF REACH OF CHILDREN:
Keep out of reach of children.
RECOMMENDED DOSAGE:
Adults: Take 10 drops under the tongue three times daily, 30 minutes before or after meals, or as directed by your health care practitioner. 1 drop = 0.05 ml.
RECOMMENDED USE:
Homeopathic remedy used to help relieve symptoms such as weakness, fatigue, cold hands and feet, dry skin, chilliness, headaches, and constipation.
Duration of Use: Consult a health care practitioner if symptoms persist or worsen.
NON-MEDICINAL INGREDIENTS:
Purified Water, Ethanol, Glycerin
QUESTIONS:
PACKAGE LABEL DISPLAY:
LIFE CHOICE
THYROID SUPPORT
SOUTIEN DE LA THYROIDE
Fatigue, cold hands and feet /
Fatigue, mains et pieds froids
Homeopathic medicine /
Remede homeopathique
60ml DIN-HM: 80025594
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0853378002547 | GTIN-13: 0853378002547 EAN-13: 0853378002547 GTIN-12: 853378002547 UPC-A: 853378002547 GTIN storage (14 digits): 00853378002547 | LFCH0002 Thyroid Support.jpg |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55856-0002-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-bdf4-f424-e053-dadaa90a57ce | DRUG FACTS: |
| 55856-0002-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-bdf4-f424-e053-dadaa90a57ce | DRUG FACTS: |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM IODIDE | ACTIVE INGREDIENT | 8EKI9QEE2H | 1 | |
| CAUSTICUM | ACTIVE INGREDIENT | DD5FO1WKFU | 1 | |
| FERROUS IODIDE | ACTIVE INGREDIENT | F5452U54PN | 1 | |
| FUCUS VESICULOSUS | ACTIVE INGREDIENT | 535G2ABX9M | 1 | |
| POTASSIUM IODIDE | ACTIVE INGREDIENT | 1C4QK22F9J | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| THYROID, BOVINE | ACTIVE INGREDIENT | MN18OTN73W | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| CAUSTICUM | ACTIVE MOIETY | DD5FO1WKFU | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| FERROUS IODIDE | ACTIVE MOIETY | F5452U54PN | 1 | |
| FUCUS VESICULOSUS | ACTIVE MOIETY | 535G2ABX9M | 1 | |
| IODIDE ION | ACTIVE MOIETY | 09G4I6V86Q | 1 | |
| THYROID, BOVINE | ACTIVE MOIETY | MN18OTN73W | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- THYROID SUPPORT
- CAUSTICUM, NATRUM MURIATICUM, CALCAREA IODATA, FUCUS VESICULOSUS, KALI IODATUM, FERRUM IODATUM, THYROIDINUM (BOVINE)
- CAUSTICUM
- SODIUM CHLORIDE
- CHLORIDE ION
- CALCIUM IODIDE
- CALCIUM CATION
- FUCUS VESICULOSUS
- POTASSIUM IODIDE
- IODIDE ION
- FERROUS IODIDE
- THYROID, BOVINE
- WATER
- ALCOHOL
- GLYCERIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55856-0002 | 55856-0002-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAUSTICUM | DD5FO1WKFU | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| CALCIUM IODIDE | 8EKI9QEE2H | ACTIB |
| FUCUS VESICULOSUS | 535G2ABX9M | ACTIB |
| POTASSIUM IODIDE | 1C4QK22F9J | ACTIM |
| FERROUS IODIDE | F5452U54PN | ACTIB |
| THYROID, BOVINE | MN18OTN73W | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2014-12-12 | full-release | 2026-06-01 02:06:15 |
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4ce2d88f-9ed1-4905-b912-c31da5f9cc4f | 6b4c9dc2-bf57-48a4-9f61-7e4a54f4eadd | 2026-06-22 | Warnings | 4ce2d88f-9ed1-4905-b912-c31da5f9cc4f 6b4c9dc2-bf57-48a4-9f61-7e4a54f4eadd |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
